ArticleScientific reports2026
Sex and age specific hormonal patterns in healthy Chinese individuals: a cross-sectional study of reproductive hormones.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Lower prolactin levels are associated with histological severity of metabolic dysfunction-associated steatotic liver disease.BMC endocrine disorders · 2026Article
- Oestradiol dynamics after polytrauma are linked to injury severity and adverse outcomes.Frontiers in endocrinology · 2026Article
- Age-related decline in AMH and gonadotropin patterns in Syrian women: Preliminary population-based estimates.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hormonal levels change with age and impact key physiological functions. However, limited data exist on age- and sex-specific hormone reference intervals in Asian populations. This study aimed to establish normative ranges for reproductive hormones in healthy Chinese adults to support age-adjusted clinical evaluations. A cross-sectional sample of 500 healthy individuals (250 males, 250 females), aged 19-70 years, was recruited from the blood transfusion department of The Affiliated Hospital of Yangzhou University. Serum samples were collected under standardized fasting and resting conditions. Steroid hormones (testosterone, estradiol, progesterone) were measured using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS), while protein hormones (LH, FSH, prolactin) were analyzed using chemiluminescent immunoassay (CLIA). Reference intervals were derived based on IFCC guidelines. Statistical analyses included ANOVA, post-hoc Tukey tests, and t-tests. In males, testosterone showed a progressive decline with age (6.0 → 3.5 ng/mL, p < 0.001), while estradiol declined modestly (35 → 25 pg/mL).Progesterone decreased gradually (0.30 → 0.15 ng/mL, p < 0.001). LH and FSH increased significantly (4.5 → 9.5 mIU/mL and 4.0 → 16.0 mIU/mL, p < 0.001), whereas prolactin remained stable (~ 8.7 ng/mL).In females, testosterone levels were lower overall (0.40 → 0.18 ng/mL), with sharp postmenopausal declines in estradiol (110 → 20 pg/mL) and progesterone (3.5 → 0.2 ng/mL).LH and FSH rose markedly after menopause (6.5 → 32.0 mIU/mL; 7.0 → 70.0 mIU/mL, p < 0.001).Prolactin remained consistent across all ages (~ 12.7 ng/mL). This study provides sex- and age-specific hormone reference intervals for a healthy Chinese population, highlighting endocrine aging patterns and the need for age-adjusted assessment. The gradual decline of progesterone in males, of uncertain clinical significance, is noted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.